Pediatric Dermatology Journal Articles

• Isotretinoin and Adverse Neuropsychiatric Outcomes Is there an association between isotretinoin treatment and severe neuropsychiatric outcomes such as such as anxiety, depression, suicidal ideation, and self-harm? This study addresses the controversy.
  The British Journal of Dermatology, August 01, 2022
• Antimicrobial Resistance and Dermatological Ramifications Dermatologist are among the most common prescribers of antibiotics, often for prolonged courses. Review strategies to combat antimicrobial resistance as it pertains to dermatology in this paper.
  The British Journal of Dermatology, July 25, 2022
• Where Are We in Understanding the Natural History of PCOS? This systemic review explores the natural history of polycystic ovary syndrome with a focus on reproductive and psychological features as well as cancer risk.
  Human Reproduction, July 22, 2022
• Targeting IL-1 Family Cytokines in Inflammatory Skin Diseases This review elucidates the role of the different IL-1 cytokines in inflammatory skin disorders. What progress is being made in developing targeted treatments to inhibit their effects?
  The British Journal of Dermatology, July 18, 2022
• Sarecycline: A Narrow-Spectrum Antibiotic Review the advantages of sarecycline, a novel narrow-spectrum tetracycline derivative for the treatment of moderate-to-severe acne.
  Skin Therapy Letter, July 18, 2022
• Impact of Medications on Anthropometric Indices in PCOS How do different pharmacologic treatment options for PCOS affect anthropometric outcomes among these women?
  Clinical Endocrinology, June 23, 2022
• JAK1 Inhibitor INCB054707 for Hidradenitis Suppurativa Review the safety and efficacy findings from two phase II studies for the JAK1 inhibitor INCB054707 in the treatment of moderate-to-severe hidradenitis suppurativa.
  The British Journal of Dermatology, June 20, 2022
• Rapid Healing and Preventing Recurrence of Venous Ulcers Learn more about a treatment strategy for the management of venous ulcers that may shorten healing time and help prevent recurrence.
  Wounds, June 13, 2022
• Corticosteroid+Glycyrrhizin for Drug-induced Liver Injury This study suggests that patients with chronic drug- or herb-induced liver injury with or without autoimmune hepatitis-like features can potentially benefit from steroid plus glycyrrhizin therapy.
  Alimentary Pharmacology & Therapeutics, May 25, 2022
• Cyanoacrylate Skin Protectant for Skin Damage in Children The application of a cyanoacrylate liquid skin protectant is a safe and effective option for managing skin damage in infants and children.
  Wounds, May 13, 2022
• Risk of Herpesvirus and Serious Infections in Atopic Dermatitis This study suggests that atopic dermatitis is associated with an increased risk of hospital admission with infections, opportunistic infections and herpesvirus infections in both children and adults.
  The British Journal of Dermatology, May 10, 2022
• Tralokinumab Plus Topical Corticosteroids in Severe AD This study evaluated the efficacy and safety of tralokinumab plus topical corticosteroids in adult patients with severe AD whose disease was not adequately controlled with ciclosporin A.
  The British Journal of Dermatology, April 11, 2022
• Female Adult Acne and Androgen Excess Find out more about the relationship between adult female acne and androgen excess -- and learn how to effectively diagnose and treat these patients.
  Journal of the Endocrine Society, April 05, 2022
• Conjunctivitis in Moderate-to-severe Atopic Dermatitis Are patients receiving tralokinumab for moderate-to-severe atopic dermatitis at increased risk of developing conjunctivitis?
  The British Journal of Dermatology, April 04, 2022
• Treating Acne in Transgender Persons Receiving Testosterone Acne is a common adverse effect among transgender patients receiving testosterone. Review the special considerations for treating acne in these patients in this paper.
  American Journal of Clinical Dermatology, March 29, 2022
• NICE Acne Guideline: What's the Latest for Dermatologists? This brief article presents a summary of updated acne guidelines developed by the UK's National Institute for Health and Care Excellence.
  The British Journal of Dermatology, March 28, 2022
• Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology This review details the mechanism of action of JAK inhibitors and assesses their efficacy and safety in the treatment of a wide variety of dermatological conditions.
  Skin Therapy Letter, March 17, 2022
• The Epidemiology of Alopecia Areata This study elucidates the epidemiology of alopecia areata, focusing on incidence, demographics and patterns of healthcare utilization.
  The British Journal of Dermatology, March 14, 2022
• Association Between Atopic Dermatitis and Hypertension This meta-analysis investigated whether persons with atopic dermatitis are at increased risk for hypertenstion.
  The British Journal of Dermatology, March 07, 2022
• Topical Clascoterone for Acne Vulgaris Review the use of clascoterone, a topical androgen receptor inhibitor, as a novel and promising therapeutic agent in the management of acne vulgaris in patients 12 years of age and older.
  Skin Therapy Letter, February 17, 2022